Paper38005258
Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.
Marras E and 12 others. Molecules, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights. Papers, record 38005258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38005258
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ruthenium | Major topic |
| Curcumin | Major topic |
| Coordination Complexes | Major topic |
| Antineoplastic Agents | Major topic |
| Photochemotherapy | Major topic |
| Humans | |
| Photosensitizing Agents | |
| Diarylheptanoids | |
| Anti-Bacterial Agents |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 2 | 34769259 | Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769259 | PubMed |
| 3 | 36978373 | The Virtuous Galleria mellonella Model for Scientific Experimentation. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36978373 | PubMed |
| 4 | 25544762 | Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. | Oncotarget | 2015 | https://conductscience.org/library/papers/25544762 | PubMed |
| 5 | 36839961 | Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839961 | PubMed |
| 6 | 21665453 | Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f. (Rubiaceae) on MCF-7c3 breast cancer cells. | Phytomedicine | 2011 | https://conductscience.org/library/papers/21665453 | PubMed |
| 7 | 27293144 | The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. | J Inorg Biochem | 2016 | https://conductscience.org/library/papers/27293144 | PubMed |
| 8 | 25344453 | Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy. | Invest New Drugs | 2015 | https://conductscience.org/library/papers/25344453 | PubMed |
| 9 | 30023938 | Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy. | ACS Omega | 2018 | https://conductscience.org/library/papers/30023938 | PubMed |
| 10 | 31137659 | NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry. | Molecules | 2019 | https://conductscience.org/library/papers/31137659 | PubMed |
| 11 | 26158541 | Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity. | Acc Chem Res | 2015 | https://conductscience.org/library/papers/26158541 | PubMed |
| 12 | 19855190 | Assessing autophagy in the context of photodynamic therapy. | Autophagy | 2010 | https://conductscience.org/library/papers/19855190 | PubMed |
| 13 | 31096157 | Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria. | Eur J Med Chem | 2019 | https://conductscience.org/library/papers/31096157 | PubMed |
| 14 | 33915370 | BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33915370 | PubMed |
| 15 | 34093012 | Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34093012 | PubMed |
| 16 | 20965744 | Antibacterial activity of anthraquinone derivatives from Heterophyllaea pustulata (Rubiaceae). | J Photochem Photobiol B | 2011 | https://conductscience.org/library/papers/20965744 | PubMed |
| 17 | 33572457 | Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases. | Biomedicines | 2021 | https://conductscience.org/library/papers/33572457 | PubMed |
| 18 | 35004350 | Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/35004350 | PubMed |
| 19 | 23993858 | Photodynamic potential of curcumin and blue LED against Streptococcus mutans in a planktonic culture. | Photodiagnosis Photodyn Ther | 2013 | https://conductscience.org/library/papers/23993858 | PubMed |
| 20 | 26202022 | p53 family members - important messengers in cell death signaling in photodynamic therapy of cancer? | Photochem Photobiol Sci | 2015 | https://conductscience.org/library/papers/26202022 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737488 | Coumarin and Curcumin-Metal Complexes as Next-Generation Photosensitizers in Cancer Photodynamic Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737488 | PubMed |
| 39771502 | Toxicological Assessment of 2-Hydroxychalcone-Mediated Photodynamic Therapy: Comparative In Vitro and In Vivo Approaches. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771502 | PubMed |
| 39496731 | Histidine containing dipeptides protect epithelial and endothelial cell barriers from methylglyoxal induced injury. | Sci Rep | 2024 | https://conductscience.org/library/papers/39496731 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAP1LC3A | 84557 | PubTator's text mining | https://conductscience.org/library/genes/84557 | NCBI Gene |
| RNASE1 | 6035 | PubTator's text mining | https://conductscience.org/library/genes/6035 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38005258
GET https://conductscience.org/api/papers/v1/38005258/references?page=2